Close Menu

NEW YORK – Noninvasive prenatal testing startup Cradle Genomics said today that it has raised $17.1 million in a Series A funding round.

The funding was led by Illumina Ventures and Section 32 with participation from Alexandria Real Estate Equities, Sea Lane Ventures, Listwin Ventures, and Axon Ventures.

The company, which is headquartered in San Diego and has R&D operations in Detroit, plans to use the proceeds to support clinical development, corporate infrastructure, CLIA lab operations, and the launch of products for NIPT.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Despite differences in their migration habits, eastern and western monarch butterflies are genetically similar, according to a study in Molecular Ecology.

The UK is implementing COVID-19 testing with a 90-minute turnaround time.

The Chan Zuckerberg Biohub is working with California's health department to sequence viral samples from COVID-19 patients to trace viral introductions, according to the San Francisco Chronicle.

In PLOS this week: identification of fungal species in subcutaneous infections, sequencing of Campylobacter found in raw meat from retail stores, and more.